Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic…

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 1 news story.

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has reversed an earlier decision…